Dexcom Inc [NASDAQ: DXCM] loss -2.99% or -2.45 points to close at $79.51 with a heavy trading volume of 5366366 shares.
The daily chart for DXCM points out that the company has recorded 9.88% gains over the past six months.
If we look at the average trading volume of 3.54M shares, DXCM reached to a volume of 5366366 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Dexcom Inc [DXCM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DXCM shares is $103.45 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DXCM stock is a recommendation set at 1.54. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Redburn Atlantic have made an estimate for Dexcom Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 03, 2025. While these analysts kept the previous recommendation, Robert W. Baird dropped their target price from $86 to $104. The new note on the price target was released on January 16, 2025, representing the official price target for Dexcom Inc stock. Previously, the target price had yet another drop from $161 to $80, while Robert W. Baird kept a Neutral rating on DXCM stock. On July 26, 2024, analysts decreased their price target for DXCM shares from 145 to 75.
The Average True Range (ATR) for Dexcom Inc is set at 2.78, with the Price to Sales ratio for DXCM stock in the period of the last 12 months amounting to 7.70. The Price to Book ratio for the last quarter was 14.77, with the Price to Cash per share for the same quarter was set at 6.60. Price to Free Cash Flow for DXCM in the course of the last twelve months was 49.26 with Quick ratio for the last quarter at 1.28.
Trading performance analysis for DXCM stock
Dexcom Inc [DXCM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.45. With this latest performance, DXCM shares dropped by -9.09% in over the last four-week period, additionally plugging by 9.88% over the last 6 months – not to mention a drop of -34.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DXCM stock in for the last two-week period is set at 34.36, with the RSI for the last a single of trading hit 26.42, and the three-weeks RSI is set at 39.92 for Dexcom Inc [DXCM]. The present Moving Average for the last 50 days of trading for this stock 84.66, while it was recorded at 83.65 for the last single week of trading, and 85.64 for the last 200 days.
Dexcom Inc [DXCM]: A deeper dive into fundamental analysis
Dexcom Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.28 and a Current Ratio set at 1.47.
Dexcom Inc [DXCM]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DXCM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Dexcom Inc go to 22.64%.
An analysis of Institutional ownership at Dexcom Inc [DXCM]
The top three institutional holders of DXCM stocks are: VANGUARD GROUP INC with ownership of 46.51 million shares, which is approximately 11.9203%. BLACKROCK INC., holding 34.52 million shares of the stock with an approximate value of $$3.91 billion in DXCM stocks shares; and BLACKROCK INC., currently with $$1.85 billion in DXCM stock with ownership which is approximately 4.0853%.
